|
Variable
|
Frequency (%)
|
|---|
|
Base line BMI
|
Low
|
387 (73.0%)
|
|
Normal
|
142 (26.8%)
|
|
Chief complain
|
Cough
|
489 (92.3%)
|
|
Othersa
|
41 (7.7%)
|
|
History of TB treatment
|
New
|
88 (16.6%)
|
|
Previously treated
|
442 (83.4)
|
|
History of injectable anti-TB drug
|
Yes
|
224 (42.3%)
|
|
No
|
306 (57.7%)
|
|
Site of DR-TB
|
Pulmonary
|
493 (93.0%)
|
|
Extra pulmonary
|
37 (7.0%)
|
|
base line sputum smear result
|
Positive
|
409 (77.2%)
|
|
Negative
|
121 (22.8%)
|
|
DR-TB diagnosed by
|
Gene Expert
|
309 (58.3%)
|
|
LPA
|
165 (31.1%)
|
|
Culture
|
56 (10.6%)
|
|
Base line functional status
|
Working
|
194 (36.6%)
|
|
Ambulatory
|
253 (47.7%)
|
|
Bedridden
|
83 (15.7%)
|
|
HIV status
|
Positive
|
143 (27.0%)
|
|
Negative
|
387 (73.0%)
|
- Treatment delay*---- in this study was considered as those DR-TB patients commenced treatment after eight days of diagnosis
- Others**------Chest pain, Weight loss, LN swelling, SOB …
- BMI Body mass index, LPA Line probe Assay, TB Tuberculosis
